Chimeric adaptor and kinase signaling proteins and their use in immunotherapy
Patent Cooperation Treaty
PCT/US2022/076358
Filed on 2022-09-13
PCT/US2022/076358
Filed on 2022-09-13
METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY
US Application 17/822,345
Filed on 2022-08-25
Filed on 2022-08-25
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Turkey
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Sweden
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Poland
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Norway
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
The Netherlands
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Italy
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Ireland
17753704.0
Filed on 2017-02-14
17753704.0
Filed on 2017-02-14